Live news related to PHARMING GROUP stock (NL0010391025): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on PHARMING GROUP mainly cover M&A activity, earnings publications et analyst notes. The stock trades at €1,09 on Euronext Paris, up 0,88% at the last update. This page lists the articles published on PHARMING GROUP stock to track the share price, company announcements and any item likely to influence market perception.
Pharming released preliminary and unaudited third-quarter data on October 22, 2026. The company advanced the full publication of its results to Octobe…
Already marketed under the name Joenja in APDS syndrome, Leniolisib was tested in 13 patients with other primary immunodeficiencies associated with im…
The Dutch biotechnology company has entrusted leadership to two incumbent executives while awaiting the appointment of a permanent successor. The depa…
On September 22, 2026, Pharming announced the acceptance of a late-breaking abstract presenting preliminary positive data from a Phase II trial conduc…
Pharming Group announced on Thursday that the FDA has accepted its supplemental New Drug Application (sNDA) for Joenja (leniolisib) to treat children …
CEO Fabrice Chouraqui will engage in a Fireside Chat session on Thursday, June 4.
The European Commission granted marketing authorization on Friday for Joenja (leniolisib), the first and only approved treatment in the European Union…
Pharming Group announced on Thursday a series of presentations at the annual congress of the Clinical Immunology Society (CIS), taking place from May …
Pharming Group announced its first quarter 2026 results on Thursday, showing an 8% decrease in total revenue to $72.4 million from $79.1 million a yea…
Pharming Group announced on Friday, March 27, 2026, that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (E…
